Cita APA

Papi, A., Jones, P. W., Dalvi, P. S., McAulay, K., McIver, T., & Dissanayake, S. (2015). The EFFECT trial: Evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD. Int J Chron Obstruct Pulmon Dis.

Chicago Style Citation

Papi, Alberto, Paul W. Jones, Prashant S. Dalvi, Kirsten McAulay, Tammy McIver, i Sanjeeva Dissanayake. "The EFFECT Trial: Evaluating Exacerbations, Biomarkers, and Safety Outcomes With Two Dose Levels of Fluticasone Propionate/formoterol in COPD." Int J Chron Obstruct Pulmon Dis 2015.

Cita MLA

Papi, Alberto, et al. "The EFFECT Trial: Evaluating Exacerbations, Biomarkers, and Safety Outcomes With Two Dose Levels of Fluticasone Propionate/formoterol in COPD." Int J Chron Obstruct Pulmon Dis 2015.